About this data
What it is
When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
Who files it
The insider, usually through the company, within two business days of the trade.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.

All of this comes from public filings.

Open-market trades per day, last 30 days

05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0
05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0

Purchases Sales

By trade date. Insiders have two business days to file, so the most recent days fill in later.

Latest open-market insider trades

Reset

Showing: ticker MCRB

Latest open-market insider trades
TradedInsiderCompanyTypeSharesPriceValueFiling
Aug 17, 2026Kelly Brady
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale64$4.55$291 SaleForm 4 ↗
Aug 17, 2026Eric D. Shaff
Director
MCRB
Seres Therapeutics, Inc.
Sale263$4.55$1,197 SaleForm 4 ↗
Aug 17, 2026Matthew R. Henn
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale81$4.55$369 SaleForm 4 ↗
Aug 17, 2026Thomas DesRosier
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale82$4.55$373 SaleForm 4 ↗
May 18, 2026Eric D. Shaff
Director
MCRB
Seres Therapeutics, Inc.
Sale259$7.53$1,950 SaleForm 4 ↗
May 18, 2026Kelly Brady
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale59$7.53$444 SaleForm 4 ↗
May 18, 2026Thomas DesRosier
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale79$7.53$595 SaleForm 4 ↗
May 18, 2026Matthew R. Henn
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale77$7.53$580 SaleForm 4 ↗
Feb 15, 2026Teresa L. Young
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale75$8.47$635 SaleForm 4 ↗
Feb 15, 2026Eric D. Shaff
Director
MCRB
Seres Therapeutics, Inc.
Sale259$8.47$2,194 SaleForm 4 ↗
Feb 15, 2026Thomas DesRosier
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale78$8.47$661 SaleForm 4 ↗
Feb 15, 2026Matthew R. Henn
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale89$8.47$754 SaleForm 4 ↗
Nov 15, 2025Thomas DesRosier
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale76$17.30$1,315 SaleForm 4 ↗
Nov 15, 2025Teresa L. Young
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale1,042$17.30$18.0K SaleForm 4 ↗
Nov 15, 2025Eric D. Shaff
Director
MCRB
Seres Therapeutics, Inc.
Sale217$17.30$3,754 SaleForm 4 ↗
Nov 15, 2025Matthew R. Henn
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale1,257$17.30$21.7K SaleForm 4 ↗
Aug 18, 2025Thomas DesRosier
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale76$16.65$1,265 SaleForm 4 ↗
Aug 18, 2025Teresa L. Young
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale59$16.65$982 SaleForm 4 ↗
Aug 18, 2025Eric D. Shaff
Director
MCRB
Seres Therapeutics, Inc.
Sale217$16.65$3,613 SaleForm 4 ↗
Aug 18, 2025Matthew R. Henn
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale73$16.65$1,215 SaleForm 4 ↗
May 16, 2025Teresa L. Young
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale63$7.28$459 SaleForm 4 ↗
May 16, 2025Eric D. Shaff
CEO and President, Director
MCRB
Seres Therapeutics, Inc.
Sale220$7.28$1,602 SaleForm 4 ↗
May 16, 2025Matthew R. Henn
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale77$7.28$561 SaleForm 4 ↗
May 15, 2025Thomas DesRosier
Chief Legal Officer and EVP
MCRB
Seres Therapeutics, Inc.
Sale79$7.28$575 SaleForm 4 ↗
Feb 18, 2025Teresa L. Young
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale3,338$0.81$2,704 SaleForm 4 ↗
Feb 18, 2025Matthew R. Henn
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale3,953$0.81$3,202 SaleForm 4 ↗
Feb 18, 2025Eric D. Shaff
CEO and President, Director
MCRB
Seres Therapeutics, Inc.
Sale12,726$0.81$10.3K SaleForm 4 ↗
Feb 18, 2025Thomas DesRosier
Chief Legal Officer and EVP
MCRB
Seres Therapeutics, Inc.
Sale4,300$0.81$3,483 SaleForm 4 ↗
Feb 18, 2025Lisa von Moltke
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale4,416$0.81$3,577 SaleForm 4 ↗
Nov 18, 2024Thomas DesRosier
Chief Legal Officer and EVP
MCRB
Seres Therapeutics, Inc.
Sale878$0.54$474 SaleForm 4 ↗
Nov 18, 2024Lisa von Moltke
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale977$0.54$528 SaleForm 4 ↗
Nov 18, 2024Teresa L. Young
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale735$0.54$397 SaleForm 4 ↗
Nov 18, 2024Matthew R. Henn
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale927$0.54$501 SaleForm 4 ↗
Nov 18, 2024Eric D. Shaff
CEO and President, Director
MCRB
Seres Therapeutics, Inc.
Sale2,505$0.54$1,353 SaleForm 4 ↗
Oct 28, 2024Lisa von Moltke
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale4,334$0.69$2,990 SaleForm 4 ↗
Oct 28, 2024Matthew R. Henn
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale3,984$0.69$2,749 SaleForm 4 ↗
Oct 28, 2024Thomas DesRosier
Chief Legal Officer and EVP
MCRB
Seres Therapeutics, Inc.
Sale4,259$0.69$2,939 SaleForm 4 ↗
Oct 28, 2024Eric D. Shaff
CEO and President, Director
MCRB
Seres Therapeutics, Inc.
Sale8,748$0.69$6,036 SaleForm 4 ↗
Oct 28, 2024Teresa L. Young
See Remarks
MCRB
Seres Therapeutics, Inc.
Sale2,983$0.69$2,058 SaleForm 4 ↗

39 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 9:24 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances